Patients How the rise of medical device use in pharma R&D is driving ... As wearable technologies continue to rapidly develop, the use cases for wearable devices evolve and expand.
Digital Digital measures and pre-competitive collaborations Digital measures from a patient’s home and known environments offer greater health insights.
News 23andMe study explains variable results with obesity drugs Gene variants could explain why some people lose more weight than others with GLP-1 drugs, and why some are more prone to side effects.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
